Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types
暂无分享,去创建一个
J. Minna | A. Gazdar | A. Virmani | D. Kodagoda | V. Tonk | J. Hung | K. Fong | D. Mcintire | Dulmini Kodagoda
[1] G. Giaccone,et al. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. , 1997, Cancer research.
[2] B. Johansson,et al. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia , 1997, Nature Genetics.
[3] W. K. Alfred Yung,et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers , 1997, Nature Genetics.
[4] M. Wigler,et al. PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.
[5] S. Hirohashi,et al. Deletion of three distinct regions on chromosome 13q in human non‐small‐cell lung cancer , 1997, International journal of cancer.
[6] A. Thor,et al. Loss of Heterozygosity in Normal Tissue Adjacent to Breast Carcinomas , 1996, Science.
[7] D A Meyers,et al. Major Susceptibility Locus for Prostate Cancer on Chromosome 1 Suggested by a Genome-Wide Search , 1996, Science.
[8] Irene L Andrulis,et al. MADR2 Maps to 18q21 and Encodes a TGFβ–Regulated MAD–Related Protein That Is Functionally Mutated in Colorectal Carcinoma , 1996, Cell.
[9] Y. Lu,et al. 2q-, a non-random chromosomal abnormality in human non-small-cell lung cancer. , 1996, Carcinogenesis.
[10] I. Newsham,et al. High-density marker analysis of 11p15.5 in non-small cell lung carcinomas reveals allelic deletion of one shared and one distinct region when compared to breast carcinomas. , 1996, Cancer research.
[11] I. Campbell,et al. Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21. , 1996, British Journal of Cancer.
[12] R. Tampé,et al. A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer , 1996, Nature Genetics.
[13] D Komitowski,et al. Allelic imbalance on chromosome 13q: evidence for the involvement of BRCA2 and RB1 in sporadic breast cancer. , 1996, Cancer research.
[14] J. Felix,et al. Potential role of the inactivated X chromosome in ovarian epithelial tumor development. , 1996, Journal of the National Cancer Institute.
[15] I. Petersen,et al. Evidence for a novel tumor suppressor gene on chromosome 15 associated with progression to a metastatic stage in breast cancer. , 1996, Oncogene.
[16] H. Koeffler,et al. Frequent loss of heterozygosity in region of the KIP1 locus in non-small cell lung cancer: evidence for a new tumor suppressor gene on the short arm of chromosome 12. , 1996, Cancer research.
[17] Scott E. Kern,et al. DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.
[18] K. Arden,et al. Allelic deletion mapping on chromosome 5 in human carcinomas. , 1996, Oncogene.
[19] A. Gazdar,et al. Cell culture methods for the establishment of the NCI series of lung cancer cell lines , 1996, Journal of cellular biochemistry. Supplement.
[20] L. Thiberville,et al. Frequency and prognostic evaluation of 3p21‐22 allelic losses in non‐small‐cell lung cancer , 1995, International journal of cancer.
[21] F. Collins,et al. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. , 1995, Human molecular genetics.
[22] G. Bepler,et al. Multiple chromosomal aberrations and 11p allelotyping in lung cancer cell lines. , 1995, Cancer genetics and cytogenetics.
[23] Kathleen R. Cho,et al. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours , 1995, Nature Genetics.
[24] C. Croce,et al. Loss of heterozygosity at chromosome 11q in lung adenocarcinoma: identification of three independent regions. , 1995, Cancer research.
[25] A. Sahin,et al. Comparative allelotype of in situ and invasive human breast cancer: high frequency of microsatellite instability in lobular breast carcinomas. , 1995, Cancer research.
[26] J. Field,et al. Loss of heterozygosity at 9p23 defines a novel locus in non-small cell lung cancer. , 1995, Oncogene.
[27] T. Polascik,et al. Novel suppressor loci on chromosome 14q in primary bladder cancer. , 1995, Cancer research.
[28] B. Neyns,et al. Frequent deletion of chromosome 19 and a rare rearrangement of 19p13.3 involving the insulin receptor gene in human ovarian cancer. , 1995, Oncogene.
[29] J. Gray,et al. Identification of novel regions of altered DNA copy number in small cell lung tumors , 1995, Genes, chromosomes & cancer.
[30] T. Sekiya,et al. Allelic losses in human chromosome II in lung cancers , 1995, Genes, chromosomes & cancer.
[31] J. Varley,et al. Frequent alterations of chromosome 1 in ductal carcinoma in situ of the breast. , 1995, Oncogene.
[32] V. Ganju,et al. Region‐specific loss of heterozygosity on chromosome 19 is related to the morphologic type of human glioma , 1995, Genes, chromosomes & cancer.
[33] F. Speleman,et al. Evidence for two tumour suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification. , 1995, Human molecular genetics.
[34] C W Caldwell,et al. Genetic alterations of microsatellites on chromosome 18 in human breast carcinoma. , 1995, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[35] J. Minna,et al. Mapping of the pulmonary surfactant SP5 (SFTP2) locus to 8p21 and characterization of a microsatellite repeat marker that shows frequent loss of heterozygosity in human carcinomas. , 1994, Genomics.
[36] Y. Nakamura,et al. Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung. , 1994, Cancer research.
[37] L. Cawkwell,et al. Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction. , 1994, British Journal of Cancer.
[38] J. Yokota,et al. Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma. , 1994, Cancer research.
[39] Y S Erozan,et al. Microsatellite alterations as clonal markers for the detection of human cancer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[40] J. Gray,et al. Identification of frequent novel genetic alterations in small cell lung carcinoma. , 1994, Cancer research.
[41] H. Sasaki,et al. Allelotype of endometrial carcinoma. , 1994, Cancer research.
[42] Yusuke Nakamura,et al. Allelotype study of esophageal carcinoma , 1994, Genes, chromosomes & cancer.
[43] S. Baylin,et al. Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer. , 1994, Cancer research.
[44] A. Balmain,et al. An allelotype of squamous carcinoma of the head and neck using microsatellite markers. , 1994, Cancer research.
[45] M. Carrington,et al. A polymorphic dinucleotide repeat in the third intron of TAP1. , 1994, Human molecular genetics.
[46] F. Kaye,et al. Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. , 1994, Oncogene.
[47] J. Yokota,et al. Homozygous deletion at chromosome 2q33 in human small-cell lung carcinoma identified by arbitrarily primed PCR genomic fingerprinting. , 1994, Oncogene.
[48] T. L. McGee,et al. Complete genomic sequence of the human retinoblastoma susceptibility gene. , 1993, Genomics.
[49] M. Knowles,et al. Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms. , 1993, Oncogene.
[50] R. Brent,et al. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites , 1993, Cell.
[51] K. Tory,et al. Molecular characterization of a large homozygous deletion in the small cell lung cancer cell line U2020: A strategy for cloning the putative tumor suppressor gene , 1992, Genes, chromosomes & cancer.
[52] Y. Nakamura,et al. Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism , 1992, Genes, chromosomes & cancer.
[53] Y. Nakamura,et al. Allelotype of non-small cell lung carcinoma--comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma. , 1992, Cancer research.
[54] J. Weber,et al. Survey of human and rat microsatellites. , 1992, Genomics.
[55] J. Minna,et al. Polymorphic sites within the MCC and APC loci reveal very frequent loss of heterozygosity in human small cell lung cancer. , 1992, Cancer research.
[56] R. Ueda,et al. The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern. , 1991, Oncogene.
[57] J. Mattick,et al. 'Touchdown' PCR to circumvent spurious priming during gene amplification. , 1991, Nucleic acids research.
[58] J. Minna,et al. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. , 1990, Oncogene.
[59] F. Collins,et al. A submicroscopic homozygous deletion at the D3S3 locus in a cell line isolated from a small cell lung carcinoma , 1990, Genes, chromosomes & cancer.
[60] C. E. Hildebrand,et al. Physical mapping of human chromosomes by repetitive sequence fingerprinting. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[61] L. Irving,et al. Cytogenetics of non‐small cell lung cancer: Analysis of consistent non‐random abnormalities , 1990, Genes, chromosomes & cancer.
[62] Y. Nakamura,et al. Allelotype of colorectal carcinomas. , 1989, Science.
[63] M. Litt,et al. A hypervariable microsatellite revealed by in vitro amplification of a dinucleotide repeat within the cardiac muscle actin gene. , 1989, American journal of human genetics.
[64] J. Minna,et al. Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer , 1985, The Journal of experimental medicine.